DOYNE MEDICAL CLINIC INC., APC
1706 W BONANZA RD, LAS VEGAS, NV 89106
NPI Number
1710997291
Practice location · View on Google Maps
SOS Verification: Pending Review
Multiple SOS Matches
Total Medicaid Payments
$558,201
-2% vs specialty average
Patients Seen
12,621
Total Claims
16,538
$ Per Patient
$44
Specialty avg: $79
Specialty Rank
#14 of 47
Clinic/Center, Primary Care providers in Nevada
Peer Average
$569,508
Average total for Clinic/Center, Primary Care
Claims per Patient
1.3
Average visits / services per person
Payments by Year
How much Medicaid paid this provider each year. Large jumps can indicate changes in practice volume or billing patterns.
| Year | Total Paid | % of Max |
|---|---|---|
| 2018 | $94,758 | |
| 2019 | $362,835 | |
| 2020 | $23,706 | |
| 2021 | $11,717 | |
| 2022 | $12,909 | |
| 2023 | $26,487 | |
| 2024 | $25,789 |
Procedure Code Breakdown
The specific medical services this provider billed Medicaid for. Each HCPCS/CPT code represents a different type of visit, test, or treatment.
| HCPCS Code | Description | Claims | Paid | % of Total | Avg per Claim |
|---|---|---|---|---|---|
| 99213 | Office visit for a simple problem (established patient) | 7,861 | $276,129 | 49.5% | $35 |
| 95004 | Allergy testing or treatment | 883 | $168,464 | 30.2% | $191 |
| 96372 | IV infusion or injection of medication | 2,112 | $48,111 | 8.6% | $23 |
| 99214 | Office visit for a moderate problem (established patient) | 448 | $16,104 | 2.9% | $36 |
| G0439 | Annual wellness visit — follow-up | 273 | $13,226 | 2.4% | $48 |
| 94060 | Breathing test or lung function test | 122 | $4,434 | 0.8% | $36 |
| 94729 | Breathing test or lung function test | 122 | $3,947 | 0.7% | $32 |
| J0696 | Injection of ceftriaxone (antibiotic, usually given for serious infections) | 225 | $3,704 | 0.7% | $16 |
| 94727 | Breathing test or lung function test | 122 | $3,051 | 0.5% | $25 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 526 | $2,679 | 0.5% | $5 |
| 92561 | Hearing or speech test or therapy | 92 | $2,496 | 0.4% | $27 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 907 | $2,494 | 0.4% | $3 |
| 99394 | Wellness checkup — ages 12-17 | 26 | $2,386 | 0.4% | $92 |
| 87880 | Strep throat test (rapid) | 276 | $1,950 | 0.3% | $7 |
| 99203 | New patient office visit — moderate problem | 27 | $1,904 | 0.3% | $71 |
| 94640 | Breathing test or lung function test | 157 | $1,149 | 0.2% | $7 |
| 99188 | Other medical service | 91 | $996 | 0.2% | $11 |
| 94200 | Breathing test or lung function test | 122 | $906 | 0.2% | $7 |
| 99393 | Wellness checkup — ages 5-11 | 13 | $899 | 0.2% | $69 |
| J1100 | Injection of dexamethasone (steroid for inflammation, allergies, or breathing problems) | 947 | $781 | 0.1% | $1 |
| G0444 | Annual depression screening | 79 | $706 | 0.1% | $9 |
| 90471 | Giving a vaccine by injection (shot) | 29 | $418 | 0.1% | $14 |
| 81000 | Urinalysis (urine test) | 141 | $267 | 0.0% | $2 |
| 71046 | Chest X-ray (two views — front and side) | 18 | $241 | 0.0% | $13 |
| 85018 | Blood cell or clotting test | 107 | $202 | 0.0% | $2 |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 24 | $172 | 0.0% | $7 |
| 94760 | Breathing test or lung function test | 149 | $149 | 0.0% | $1 |
| A7015 | Aerosol mask, used with medical equipment nebulizer | 114 | $145 | 0.0% | $1 |
| J1020 | Injection, methylprednisolone acetate, 20 mg | 17 | $66 | 0.0% | $4 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through medical equipment, unit dose, 1 mg | 149 | $23 | 0.0% | $0 |
| 99173 | Other medical service | 84 | $0 | 0.0% | $0 |
| 99000 | Special medical service | 261 | $0 | 0.0% | $0 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 14 | $0 | 0.0% | $0 |
About This Data
This data comes from the HHS Medicaid Provider Spending dataset (opendata.hhs.gov). It shows payments made through Nevada Medicaid from 2018–2024. High payments do not mean a provider is doing anything wrong — some specialties naturally cost more, and busy providers see more patients. But unusually high numbers compared to peers can be worth a closer look.